Jianhua Chen Selected Research

Jianhua Chen Research Topics

Disease

66	Neoplasms (Cancer) 04/2024 - 09/2004
31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 09/2013
11	Schizophrenia (Dementia Praecox) 12/2024 - 01/2012
11	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2013
8	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2004
7	Type 2 Diabetes Mellitus (MODY) 12/2024 - 09/2012
6	Disease Progression 02/2024 - 09/2013
6	Hypoxia (Hypoxemia) 02/2022 - 01/2013
6	Neutropenia 01/2022 - 01/2014
6	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2013
6	Gout 01/2022 - 05/2015
6	Leukopenia 01/2022 - 03/2015
5	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 10/2016
4	Seizures (Absence Seizure) 04/2023 - 01/2013
4	Melanoma (Melanoma, Malignant) 12/2022 - 01/2019
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2018
4	Exanthema (Rash) 01/2022 - 09/2013
4	Hyperuricemia 01/2022 - 05/2016
4	Carcinoma (Carcinomatosis) 08/2021 - 09/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2024 - 01/2015
3	COVID-19 03/2024 - 01/2022
3	Major Depressive Disorder (Major Depressive Disorders) 12/2023 - 10/2015
3	Inflammation (Inflammations) 12/2023 - 11/2021
3	Infections 07/2023 - 01/2020
3	Fever (Fevers) 07/2023 - 07/2010
3	Esophageal Squamous Cell Carcinoma 10/2022 - 01/2020
3	Diarrhea 10/2022 - 01/2022
3	Adenocarcinoma of Lung 07/2022 - 01/2020
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 08/2013
3	Rectal Neoplasms (Rectal Cancer) 07/2021 - 01/2020
3	Glioma (Gliomas) 01/2021 - 07/2017
3	Anemia 01/2021 - 01/2014
3	Epilepsy (Aura) 01/2021 - 01/2013
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 01/2017
3	Mental Disorders (Mental Disorder) 10/2015 - 01/2014
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 09/2011
2	Stomach Neoplasms (Stomach Cancer) 10/2023 - 01/2020
2	Substance-Related Disorders (Drug Abuse) 01/2023 - 01/2021
2	Dementia (Dementias) 01/2023 - 01/2014
2	Macular Degeneration (Age-Related Maculopathy) 12/2022 - 09/2011
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2013
15	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2012
8	camrelizumabIBA 07/2023 - 01/2020
7	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 11/2004
7	Peptides (Polypeptides)IBA 04/2014 - 09/2004
6	RNA (Ribonucleic Acid)IBA 12/2024 - 11/2020
6	Pemetrexed (MTA)FDA Link 01/2022 - 01/2014
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 12/2014
5	CollagenIBA 12/2023 - 01/2019
5	Immune Checkpoint InhibitorsIBA 12/2022 - 12/2019
5	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2022 - 01/2013
5	Uric Acid (Urate)IBA 01/2022 - 05/2015
5	PlatinumIBA 01/2022 - 01/2014
4	Antipsychotic Agents (Antipsychotics)IBA 12/2024 - 01/2015
4	CrizotinibIBA 02/2024 - 01/2020
4	Docetaxel (Taxotere)FDA Link 10/2022 - 01/2014
4	Adenosine Triphosphate (ATP)IBA 02/2022 - 01/2019
4	Clozapine (Clozaril)FDA LinkGeneric 06/2021 - 01/2015
4	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
4	Cadherins (E-Cadherin)IBA 01/2020 - 03/2014
4	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2007 - 02/2005
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 03/2023
3	ensartinibIBA 02/2024 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 01/2018
3	Messenger RNA (mRNA)IBA 12/2023 - 01/2016
3	Therapeutic UsesIBA 12/2022 - 10/2020
3	LigandsIBA 12/2022 - 04/2020
3	Programmed Cell Death 1 ReceptorIBA 10/2022 - 01/2022
3	AcidsIBA 07/2022 - 09/2005
3	Nucleic AcidsIBA 01/2022 - 11/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2011
3	Circulating Tumor DNAIBA 01/2021 - 11/2019
3	Cysteine (L-Cysteine)FDA Link 01/2021 - 05/2019
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2019
3	Small Interfering RNA (siRNA)IBA 01/2020 - 07/2017
3	MutagensIBA 04/2014 - 11/2004
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2007 - 02/2005
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2007 - 09/2005
2	Carrier Proteins (Binding Protein)IBA 04/2024 - 10/2012
2	Anaplastic Lymphoma KinaseIBA 02/2024 - 01/2024
2	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2020
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2023 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 01/2013
2	sugemalimabIBA 01/2023 - 01/2022
2	AntibodiesIBA 12/2022 - 09/2009
2	Gefitinib (Iressa)FDA Link 01/2022 - 09/2013
2	MetalsIBA 01/2022 - 01/2018
2	Monoclonal AntibodiesIBA 01/2022 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2021

Therapy/Procedure

30	Therapeutics 01/2024 - 11/2004
22	Drug Therapy (Chemotherapy) 01/2024 - 01/2014
6	Immunotherapy 08/2023 - 12/2019
6	Radiotherapy 11/2017 - 09/2004
3	Chemoradiotherapy 01/2024 - 01/2020
3	Radiofrequency Ablation 01/2022 - 01/2021
2	Moxibustion 01/2023 - 01/2022
2	Lasers (Laser) 09/2022 - 02/2022
2	Catheter Ablation 01/2022 - 08/2021
2	Aftercare (After-Treatment) 01/2022 - 01/2021